99mTc-dextran-antibody conjugates - Labelling procedures

Acta Oncologica

Volumn 35, Issue 4, 1996, Pages 489-492

  Márquez, Marcela ^a   Westlin, Jan Erik ^a   Nilsson, Sten ^a   Holmberg, Anders R ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; DEXTRAN; DEXTRAN ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TC 99M; TECHNETIUM 99M; ALCOHOL; CHELATING AGENT; DIAGNOSTIC AGENT; HYDROCHLORIC ACID; KERATIN; LIGAND; OXYGEN; STANNOUS CHLORIDE; TARTARIC ACID; TARTARIC ACID DERIVATIVE; TECHNETIUM; TECHNETIUM COMPLEX; TECHNETIUM TC 99M DEXTRAN; TIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ISOTOPE LABELING; PRIORITY JOURNAL; SCINTIGRAPHY; TOMOSCINTIGRAPHY; CHEMISTRY; COMPARATIVE STUDY; GEL CHROMATOGRAPHY; IMMUNOLOGY; OXIDATION REDUCTION REACTION; PH; RADIOIMMUNOASSAY; REPRODUCIBILITY; SCINTISCANNING; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; TOMOGRAPHY;

ANTIBODIES, MONOCLONAL; CHELATING AGENTS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, THIN LAYER; DEXTRANS; ETHANOL; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; KERATINS; LIGANDS; ORGANOTECHNETIUM COMPOUNDS; OXIDATION-REDUCTION; OXYGEN; RADIOIMMUNODETECTION; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; TARTRATES; TECHNETIUM; TIN COMPOUNDS; TOMOGRAPHY, X-RAY;

EID: 0029666083     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609109928     Document Type: Article

References (15)

1. Khaw BA, Strauss W, Carvalho A, Locke E, Gold H, Haber E. Tc-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen. J Nucl Med 1982; 23: 1011-9.
2. Paik CH, Lan NB, Hong JJ, et al. The labeling of high affinity sites of antibodies with Tc-99m. Nucl Med Biol 1985; 12: 3-8.
3. Franz J, Volkert W, Barefield EK, Holmes RA. The production of Tc-99m labelled conjugated antibodies using a cyclambased bifunctional chelating agent. Nucl Med Biol 1987; 14: 569-72.
4. Rhodes BA, Zamora PA, Newell KD, et al. Tc-99m labelling of murine monoclonal antibody fragments. J Nucl Med 1986; 27: 685-93.
5. Schwartz A, Steinstrabber A. A novel approach to Tc-99m labelled monoclonal antibodies. J Nucl Med 1986; 28: 721.
6. Thakur ML, DeFulvio J, Richard MD, Park CH. Technetium-99m labelled monoclonal antibodies: Evaluation of reducing agents. Nucl Med Biol 1991; 18: 227-33.
7. Henize E, Robinson GD, Kuhl DE, Schelbert HR. Tc-99m dextran: A new blood-pool labeling agent for radionuclide angiocardiography. J Nucl Med 1982; 23: 348-53.
8. 99mTc as a lymphoscintigraphic agent in rabbits. Eur J Nucl Med 1982; 11: 80-4.
9. 99mTc-dextran. Nucl Med Comm 1988; 9: 657-62.
10. 99mTc-dextrans for lymphoscintigraphy. Eur J Nucl Med 1989; 15: 146-51.
11. De Kievet W. Technetium radiopharmaceuticals: Chemical characterisation and tissue distribution of Tc-Glucoheptonate using Tc-99m and carrier Tc-99. J Nucl Med 1981; 22: 703-9.
12. Borch RF, Bernstein MD, Dupont Durst H. The cyanohydridoborate as a selective reducing agent. J Am Chem Soc 1971; 6: 2897-904.
13. Foster RL. Preparation and properties of a soluble trypsindextran conjugate. Experentia 1975; 31; 772-3.
14. 99mTc. Anibody Immunoconj Radiopharmaceut 1994; 7: 149-54.
15. Schwochau K. Technetium radiopharmaceuticals - fundamentals, synthesis, structure, and development. Angew Chem Int Ed Engl 1994; 33: 2258-67.